129 related articles for article (PubMed ID: 2529149)
1. Calmodulin inhibition by anthralin? Investigations in vitro and in vivo.
Wollina U; Klinger R; Wetzker R; Knopf B
Dermatologica; 1989; 179(2):61-3. PubMed ID: 2529149
[TBL] [Abstract][Full Text] [Related]
2. Epidermal calmodulin levels in psoriasis before & after therapy.
Kaur I; Kaur S; Vaishnavi C; Ganguly NK; Garg J; Kohli M
Indian J Med Res; 1991 Apr; 94():130-3. PubMed ID: 1879887
[TBL] [Abstract][Full Text] [Related]
3. Progressive decline in the ability of calmodulin isolated from aged brain to activate the plasma membrane Ca-ATPase.
Gao J; Yin D; Yao Y; Williams TD; Squier TC
Biochemistry; 1998 Jun; 37(26):9536-48. PubMed ID: 9649337
[TBL] [Abstract][Full Text] [Related]
4. Differential inhibition of calmodulin-sensitive phosphodiesterase and Ca++-adenosine triphosphatase by chlorpromazine-linked calmodulin.
Prozialeck WC; Wallace TL; Weiss B
J Pharmacol Exp Ther; 1987 Oct; 243(1):171-9. PubMed ID: 2822896
[TBL] [Abstract][Full Text] [Related]
5. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
Yamamoto T; Nishioka K
Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
[TBL] [Abstract][Full Text] [Related]
6. Anthralin inhibits elevated levels of thioredoxin reductase in psoriasis. A new mode of action for this drug.
Schallreuter KU; Pittelkow MR
Arch Dermatol; 1987 Nov; 123(11):1494-8. PubMed ID: 2445297
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence remission spectroscopy of psoriatic lesions and the effect of topical anthralin therapy.
Wollina U; Schmidt WD; Koch A; Scheibe A; Erfurth F; Fassler D
J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1409-13. PubMed ID: 19508501
[TBL] [Abstract][Full Text] [Related]
8. Antipsoriatic drug anthralin induces EGF receptor phosphorylation in keratinocytes: requirement for H(2)O(2) generation.
Peus D; Beyerle A; Vasa M; Pott M; Meves A; Pittelkow MR
Exp Dermatol; 2004 Feb; 13(2):78-85. PubMed ID: 15009100
[TBL] [Abstract][Full Text] [Related]
9. An investigation of the ability of antipsoriatic drugs to inhibit calmodulin activity: a possible mode of action of dithranol (anthralin).
Tucker WF; MacNeil S; Dawson RA; Tomlinson S; Bleehen SS
J Invest Dermatol; 1986 Aug; 87(2):232-5. PubMed ID: 3016102
[TBL] [Abstract][Full Text] [Related]
10. Dynamic structure of the calmodulin-binding domain of the plasma membrane Ca-ATPase in native erythrocyte ghost membranes.
Yao Y; Gao J; Squier TC
Biochemistry; 1996 Sep; 35(37):12015-28. PubMed ID: 8810906
[TBL] [Abstract][Full Text] [Related]
11. Oxidative inactivation of purified plasma membrane Ca2+-ATPase by hydrogen peroxide and protection by calmodulin.
Zaidi A; Barŕon L; Sharov VS; Schöneich C; Michaelis EK; Michaelis ML
Biochemistry; 2003 Oct; 42(41):12001-10. PubMed ID: 14556631
[TBL] [Abstract][Full Text] [Related]
12. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC
J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of calmodulin stimulation of phosphodiesterase and Ca2+, Mg2+-ATPase activities and shape change of erythrocyte ghosts by chloroquine.
Nagai F; Ushiyama K; Kano I; Nakagawa A; Nakao T; Nakajima A
Biochem Pharmacol; 1987 Oct; 36(20):3433-7. PubMed ID: 2960325
[TBL] [Abstract][Full Text] [Related]
14. Anthralin: how does it act and are there more favourable derivatives?
Mahrle G; Bonnekoh B; Wevers A; Hegemann L
Acta Derm Venereol Suppl (Stockh); 1994; 186():83-4. PubMed ID: 8073848
[TBL] [Abstract][Full Text] [Related]
15. Anti-psoriatic drug anthralin activates transcription factor NF-kappa B in murine keratinocytes.
Schmidt KN; Podda M; Packer L; Baeuerle PA
J Immunol; 1996 Jun; 156(11):4514-9. PubMed ID: 8666828
[TBL] [Abstract][Full Text] [Related]
16. Oxidation of Met144 and Met145 in calmodulin blocks calmodulin dependent activation of the plasma membrane Ca-ATPase.
Bartlett RK; Bieber Urbauer RJ; Anbanandam A; Smallwood HS; Urbauer JL; Squier TC
Biochemistry; 2003 Mar; 42(11):3231-8. PubMed ID: 12641454
[TBL] [Abstract][Full Text] [Related]
17. The role of calcium and calmodulin in freezing-induced freezing resistance of Populus tomentosa cuttings.
Lin SZ; Zhang ZY; Lin YZ; Zhang Q; Guo H
Zhi Wu Sheng Li Yu Fen Zi Sheng Wu Xue Xue Bao; 2004 Feb; 30(1):59-68. PubMed ID: 15583410
[TBL] [Abstract][Full Text] [Related]
18. Single-molecule characterization of the dynamics of calmodulin bound to oxidatively modified plasma-membrane Ca2+-ATPase.
Osborn KD; Zaidi A; Urbauer RJ; Michaelis ML; Johnson CK
Biochemistry; 2005 Aug; 44(33):11074-81. PubMed ID: 16101291
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of the intracellular Ca(2+)-ATPase in cultured mouse keratinocytes reveal components of terminal differentiation that are regulated by distinct intracellular Ca2+ compartments.
Li L; Tucker RW; Hennings H; Yuspa SH
Cell Growth Differ; 1995 Sep; 6(9):1171-84. PubMed ID: 8519694
[TBL] [Abstract][Full Text] [Related]
20. Purification, characterization, and reconstitution of the Ca2+-transport system (high-affinity Ca2+, Mg2+-ATPase) of the human erythrocyte membrane.
Gietzen K; Konrad R; Tejcka M; Fleischer S; Wolf HU
Acta Biol Med Ger; 1981; 40(4-5):443-56. PubMed ID: 6118989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
